Where does Bloodworks rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bloodworks ranks #13,327 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bloodworks hold?

Bloodworks holds 22 US utility patents granted between 2017 and 2022, spanning 13 technology areas.

What is Bloodworks's Innovation Score?

Bloodworks has an Innovation Score of 33.0 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bloodworks focus on?

Bloodworks's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 16 patents, ranking #956 of 7,863 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Bloodworks's patent grant rate increasing or decreasing?

Bloodworks's recent grant velocity is +44% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bloodworks's patents?

Bloodworks's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bloodworks patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bloodworks

USPTO PatentsView assignee record - 22 granted patents across 13 technology areas, recorded in grant years 2017–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bloodworks ranks #13,327 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 13 technology areas.

#13,327
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.0/100): 15.0
avg claims per patent: +44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13327 · US Corporation #13,327 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,327/49,997
PHOTO-FINISH Baram International
CPC-FOCUS G01N · 13 areas
INNOV-THIN 33.0/100
CLAIMS-RICH 15.0 claims/avg
TYPE-USCORP US Corporation
VEL-UP +44% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Baram International Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bloodworks’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (33%) Velocity 0.4 pts (1%) Breadth 12.7 pts (39%) Claim depth 9.0 pts (27%)

Qualcomm Incorporated · highest

85
Bloodworks · this assignee

33
3D Lighting… · lowest

7

What this shows Bloodworks's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bloodworks?

Each dot is one of Bloodworks’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bloodworks’s own 15.0 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bloodworks vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bloodworks's grants concentrate

Bloodworks is a focused PatentsView assignee: 13 CPC subclasses with 72.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (8 grants) versus a trough of 1 in 2022. By volume, Bloodworks sits between Baram International Co., Ltd. and Broadcom Europe Limited.

Bloodworks's three-year grant acceleration

Bloodworks shows 1 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Baram Internation…

22
Beijing 7invensun…

22
Biodlogics

22
Blancco Technolog…

22
Bodor Laboratories

22
Boyce Thompson In…

22
BPW Bergische Ach…

22
Broadcom Europe

22
Bloodworks ◀

22

What this shows Bloodworks holds 22 patents at rank #13,321, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bloodworks

By rank, the assignees closest to #13,321 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Bloodworks's primary technology class.

Bloodworks's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Bloodworks patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	9.1%
2018	2	9.1%
2019	5	22.7%
2020	8	36.4%
2021	4	18.2%
2022	1	4.5%

Which technologies does Bloodworks patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C07K - Peptides 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bloodworks's patent record in context - here's where to go next.

Bloodworks's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 72.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #13,327 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bloodworks against Baram International Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.